The Scientist Names IsoPlexis Technology The Top Innovation of 2017

IsoPlexis’ IsoCode Chip, its next-generation technology capable of identifying and predicting patient responses to immunotherapy, was recognized as the top innovation of 2017 by The Scientist. IsoPlexis’ single-cell technology was recognized as a detection system poised to revolutionize clinical research and advance scientific knowledge. The Scientist’s jury member Cruickshaw-Quinn stated: “The IsoLight single-cell technology, with its ease-of-use, has the potential to impact cancer research for both biomarker discovery and patient monitoring.”

Share This Article
Be in the Know.
Unlock Resources

We will always keep your personal information safe. Complete this form to get unlimited access to all of our web resources and join over 10,000 leading researchers who receive industry pioneers' backed data straight to their inbox. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.